Losartan drug recall expanded to include five more lots
FDA announces the voluntary recall for the losartan medications has been extended to include more lots, after impurities were found in the drugs.
List view / Grid view
News
Global injectable drug delivery market predicted to grow 12.8 percent
Increasing demand for convenient drug delivery, as well as an increase in diseases such as diabetes, has fuelled the global injectable drug delivery market.
Two drug firms admit to colluding to keep prices up
King Pharmaceuticals Limited and Alissa Healthcare Research Limited have admitted to sharing information to keep drug prices up.
CBD – the science behind purity
An event was held last week, exploring the manufacturing and potential of cannabinoids within the pharmaceutical industry.
EMA CHMP recommends seven medicines for approval
The EMA has suggested seven treatments to be granted marketing authorisations and also advocated indication extension for eight drugs.
First oral GLP-1 treatment for type 2 diabetes approved
With the approval of the treatment, Rybelsus, there is a new option for treating type 2 diabetes without injections.
Partnership between the BP and USP to be formalised
The British Pharmacopoeia and United States Pharmacopeia partnership is to be formalised to strengthen the quality of medicines and public health.
EPIDYOLEX® receives marketing authorisation in Europe
The cannabidiol-based treatment EPIDYOLEX has been granted marketing authorisation from the European Commission.
DRC announces plans to use second Ebola vaccine
Health authorities in the Democratic Republic of Congo are planning to use a second vaccine to treat the Ebola virus.
Treatment for dialysis patients with CKD anaemia approved in Japan
A treatment for anaemia associated with chronic kidney disease in dialysis patients has been approved in Japan.
Two lots of quinacrine recalled due to labelling error
Darmerica LLC is voluntarily recalling two lots of quinacrine dihydrochloride due to a label mix-up.
Drones set to deliver drugs to remote parts of India by 2020
The government of an Indian province and a US company have teamed together in an initiative to deliver medications to remote regions using drones, which should begin next year.
New cancer drugs approvals underpinned by flawed evidence
A new report has shown that trial evidence alone is not enough when approving new cancer drugs and that an assessment of that evidence is also needed.
FDA accepts Biologics License Application for V920 Ebola vaccine
A Biologics License Application and priority review has been approved by the FDA for an investigational Ebola vaccine.
Hereditary angioedema treatment recommended by NICE
Lanadelumab, a preventive treatment for hereditary angioedema, has been recommended as a cost-effective use of NHS resources.
